Skip to main
OFIX

Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix International (OFIX) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Orthofix Medical is poised for growth in the medical device industry due to its diverse product portfolio, with the majority of its revenue coming from the profitable Global Spine segment. This segment has a strong track record of delivering innovative and highly sought-after solutions for spinal procedures, making it a key driver for the company's success. Additionally, the company's focus on digital technologies for limb reconstruction in its Global Limb Reconstruction segment further showcases its commitment to staying ahead of the curve and sustaining long-term growth.

Bears say

Orthofix Medical is facing potential challenges due to a recent 10% reimbursement cut, as well as the unusual and rushed reclassification of bone growth stimulator devices to Class II. Additionally, the company's recent strategic realignment, including eliminating a leadership role and combining other segments under one leader, may lead to disruptions and uncertainties within the organization. These factors may negatively impact the company's financial performance and growth potential, leading to a negative outlook on its stock.

Orthofix International (OFIX) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Orthofix International (OFIX) Forecast

Analysts have given Orthofix International (OFIX) a Buy based on their latest research and market trends.

According to 4 analysts, Orthofix International (OFIX) has a Buy consensus rating as of Aug 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Orthofix International (OFIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.